Farmasi Arena
indoor multi-purpose arena in Rio de Janeiro, Brazil
Farmasi Arena is an indoor multipurpose arena, located in the region of Barra da Tijuca, in Rio de Janeiro, Brazil. It is one of the indoor arena with largest capacity in the country, with 15,430 people for sports and up to 18,768 for concerts.
The arena is named for the Turkish cosmetics company Farmasi through a naming rights deal closed in 2024. Priorly, the arena was sponsored by the American cosmetics company Jeunesse Global from 2017 to 2023, and British bank HSBC. The arena was completed in July 2007 and was first known as Arena Olímpica do Rio (Rio Olympic Arena), which it was known as during the 2016 Summer Olympics. From December 2007 to March 2008, plus the months between Jeunesse's deal expiring and Farmasi taking over, it was known as RioArena.
Sports
The arena was built to host basketball and gymnastics during the 2007 Pan American Games. In December 2007, it started being operated by GL events, who also operates the nearby Riocentro Convention Center and the Riocentro Sports Complex, and started hosting many concerts from a variety of artists. It has also hosted the UNESCO teleton, Criança Esperança, after 2008, replacing Ginásio do Ibirapuera in São Paulo as the main venue. Starting on 29 March 2008, it was renamed as the HSBC Arena, as part of a naming rights agreement with the bank.
The arena hosted UFC's first event in Brazil in thirteen years, UFC 134: Silva vs.
“Farmasi Arena” enters the record as indoor multi-purpose arena in Rio de Janeiro, Brazil. Crown Archives preserves that source wording while asking what Farmasi, Arena and indoor can confirm, complicate or overturn.
Why this record matters
“Farmasi Arena” is worth following because a concise public description often conceals a longer documentary argument. Here, Farmasi, Arena and indoor provides the most credible route into that argument.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Sep 19, 2026. The linked authority identifier is Q1507437. Authority coordinates are -22.975, -43.390. 3 of 3 selected statements include explicit references; 0 carry qualifiers and 0 use preferred rank. The first chronological checks are 2024, 2017, 2023 and 2007.
Overview language is designed for orientation and should not be treated as a substitute for the evidence cited beneath it. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Farmasi Arena”, its source revision and the description used here.
- Expand the search: follow Farmasi Arena primary sources, Farmasi Arena archive and Farmasi research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Farmasi Arena”?
- What terminology or title could unlock a more precise catalogue search?
- Which institution is responsible for the underlying evidence?
Search terms from this dossier
This entry incorporates text from “Farmasi Arena” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.